2009
DOI: 10.2174/092986709788682029
|View full text |Cite
|
Sign up to set email alerts
|

DD-Ligases as a Potential Target for Antibiotics: Past, Present and Future

Abstract: DD-ligases catalyze the synthesis of the D-Ala-D-Ala and D-Ala-D-Ser dipeptides or the D Ala-D-Lac depsipeptide in an early step of peptidoglycan synthesis. Their function is essential for bacterial growth and specific to bacteria, making them attractive targets for the development of novel antibiotics. This review examines the biochemical and structural features of these enzymes and presents the main families of inhibitors described so far. Over the last 20 years, 7 structures of DD-ligases have been solved b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
30
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(31 citation statements)
references
References 111 publications
(178 reference statements)
1
30
0
Order By: Relevance
“…Residues 206−220 constitute the head of the lid loop and include a two-turn α-helix (residues 212−217). 15 The proximity of hinge residues 200 and 226 qualifies the Ddl lid loop as an ω-loop protein motif. 16 During its catalytic cycle, DdlB undergoes two major conformational changes.…”
mentioning
confidence: 99%
“…Residues 206−220 constitute the head of the lid loop and include a two-turn α-helix (residues 212−217). 15 The proximity of hinge residues 200 and 226 qualifies the Ddl lid loop as an ω-loop protein motif. 16 During its catalytic cycle, DdlB undergoes two major conformational changes.…”
mentioning
confidence: 99%
“…Correlation is not perfect, however as IT8, which is only 3 times less potent on ligase than IT16, is unable to prevent bacterial growth. Among the families of inhibitors described so far, only a few were tested for their antimicrobial activity [12]. In these studies also, there was no clear correlation between enzymatic inhibition and antimicrobial potency, as illustrated for (i) diazenecarboxamides [14], which show IC 50 towards Ddl 20 times lower than d-cycloserine but higher MICs, (ii) the natural compound quercetin [49], which shows lower IC 50 and K i values than apigenin towards the H. pylori enzyme, but 8 times higher MIC towards the bacterium, or (iii) two molecules from the NCI database [16] which display similar MIC towards S. aureus but K i differing by one order of magnitude.…”
Section: Rational Design Of Inhibitorsmentioning
confidence: 99%
“…The development of synthetic inhibitors has recently regained interest, and new ligands have been identified [12]. Most of them were discovered by screening of chemical banks [13 -16] with one active compound (3-chloro-2,2-dimethyl-N-[4(trifluoromethyl) phenyl]propanamide) subsequently shown by X-ray crystallography to bind in a pocket adjacent to the substrate binding site [13].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Ddl catalyzes the ATP-dependent formation of a dipeptide D-Ala-D-Ala that subsequently occupies the terminal position of the cell wall UDP-Mur N Ac-pentapeptide precursor units. This terminal dipeptide plays a pivotal role in the extracellular steps of peptidoglycan assembly, where cross-linking of adjacent peptidoglycan chains occurs via breaking a dipeptide bond and forming a new one [10].…”
Section: Introductionmentioning
confidence: 99%